BluePointe Capital Management’s Abbott ABT Stock Holding History

BluePointe Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$220K	Buy	+1,658	New	+$211K	0.08%	119

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BluePointe Capital Management's ABT Position: Q1 2025 in Review

BluePointe Capital Management opened a new position in Abbott (ABT) in Q1 2025: 1,658 shares worth $220K. The stake represents 0.08% of the portfolio and ranks #119 among its holdings.

3,176 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

BluePointe Capital Management held 1,658 shares of Abbott worth $220K as of Q1 2025.
Abbott was a new BluePointe Capital Management position in Q1 2025.
Abbott made up 0.08% of BluePointe Capital Management's portfolio in Q1 2025, its #119 holding.
3,176 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on BluePointe Capital Management's 13F filing for Q1 2025, filed 2 May 2025.